Table 5.
The published and validated model equations that are used together with the measured properties to estimate the in vivo distribution behaviour of drugs. (abbreviations: IAM = Immobilized Artificial Membrane; HSA = Human Serum Albumin; Vd = volume of distribution; Vdu = Unbound volume of distribution, DEmax = maximum drug efficiency; BTB = brain tissue binding; PPB = plasma protein binding, fu = unbound fraction; Kbb = brain to blood partition coefficient; Kpcell = cell partition coefficient; LTB = lung tissue binding)
| log K IAM [43] | = 0.29*e(0.026CHI(IAM)+0.42) +0.7 |
| log k IAM [43] | = 0.046*CHI(IAM)+0.42 |
| Phospholipidotic potential (CAD-likeness) | = CHI (IAM) + (CHI at pH 10.5 – CHI at pH 7.4) |
| log K HSA [43] | = elog k(HSA) |
| log k HSA [30] | = log (%HSAbound/(101- %HSA bound)) |
| Estimated log Vd [43,44] | = 0.44*log K IAM -0.22*log K HSA – 0.62 |
| Estimated log Vdu[27] | = 0.23*log K HSA +0.43*log K IAM -0.72 |
| DEmax [45] | = 100/Vdu |
| log k BTB [31] | = 1.29*log k IAM+1.03*log k HSA-2.37 |
| log k (PPB)[31] | = 0.98*log k HSA+0.19*log k AGP+0 .031*CHI log D 7.4-0.20 |
| %BTB [31] | = 100*10log k BTB/(1+10log k BTB) |
| %PPB [31] | = 100*10log k PPB/(1+10log k PPB) |
| fu BTB and PPB [31] | = (100-%BTB)/100 and (100 %-%PPB)/100 |
| Kbb [31] | = fuPPB/fuBTB |
| log Kpcell [46] | = 1.1log k IAM-1.9 |
| log k LTB [31] | = 0.49*log k PPB+0.34CHIlog D-0.069 |
| % LTB [31] | = 100*10logkLTB/(1+10logkLTB) |